(Reuters) – Biotechnology company ArQule Inc (ARQL.O) said its lead experimental lung cancer drug showed positive results in a mid-stage trial, sending its shares up to a new two-year high. The drug, ARQ 197, when used with another lung cancer drug, erlotinib, showed a 66 percent improvement in median progression-free survival (PFS) — the time [...]
Wall to Wall Street Coverage: Upgrades and Downgrades
March 31st, 2010
Comments: 0
It was another day, another 18-month high for the Dow. Equities were boosted by an increase in January’s S&P/Case-Shiller home price index which surprised some. (Easy annual comps on the worth of the White House may have helped inflate real estate in the Washington area.) Looking back was similarly fruitful for Apple (AAPL). A decade [...]
Lyric Jeans, Inc. to Update Pink Sheet Information
March 30th, 2010
Comments: 0
LOS ANGELES, CA–(Marketwire – 03/26/10) – Lyric Jeans, Inc. (Pinksheets:LYJN – News) today announced that it has taken the steps necessary to become a Pink Sheets reporting company including entering into the Pink OTC Markets Issuer Services Agreement and assembling the information as required by Pink Sheets Guidelines for Providing Adequate Current Information. “The company [...]
Day Traders 2.0: Wired, Angry and Loving It
March 29th, 2010
Comments: 0
Remember the day traders? They were hard to miss during the tech-stock mania a decade ago, when the Nasdaq seemed like a casino built by morons and a chimp with darts could pick winners. You would hear about these guys — nearly all of them were guys — and wonder: Could anyone make a living [...]
Stock futures point to higher opening
March 29th, 2010
Comments: 0
NEW YORK (AP) — Stock futures are rising Monday as investors grow more comfortable about a global economic recovery. Consumer spending rose for the fifth consecutive month in February, matching economists’ expectations, according to a new government report. At the end of the week, investors will get the Labor Department’s monthly employment report, which is [...]
